Diploma (LON:DPLM) Reaches New 12-Month High at $3,870.00

Diploma PLC (LON:DPLMGet Free Report)’s share price reached a new 52-week high during trading on Wednesday . The company traded as high as GBX 3,870 ($48.91) and last traded at GBX 3,826 ($48.35), with a volume of 176315 shares. The stock had previously closed at GBX 3,426 ($43.30).

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on DPLM shares. Shore Capital reissued a “buy” rating on shares of Diploma in a research note on Wednesday. Berenberg Bank lifted their price target on shares of Diploma from GBX 3,800 ($48.02) to GBX 4,400 ($55.60) and gave the company a “buy” rating in a research note on Thursday.

Check Out Our Latest Stock Report on DPLM

Diploma Price Performance

The business has a 50-day moving average price of GBX 3,381.72 and a two-hundred day moving average price of GBX 3,250.80. The company has a quick ratio of 0.80, a current ratio of 2.06 and a debt-to-equity ratio of 44.05. The company has a market capitalization of £4.99 billion, a price-to-earnings ratio of 4,135.56, a price-to-earnings-growth ratio of 2.82 and a beta of 0.73.

Diploma Increases Dividend

The firm also recently disclosed a dividend, which was paid on Friday, February 2nd. Shareholders of record on Thursday, January 18th were paid a GBX 40 ($0.51) dividend. This represents a dividend yield of 1.32%. This is a positive change from Diploma’s previous dividend of $16.50. The ex-dividend date was Thursday, January 18th. Diploma’s dividend payout ratio (DPR) is 6,333.33%.

About Diploma

(Get Free Report)

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.

Recommended Stories

Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.